Wird geladen...
Engineered antibodies: new possibilities for brain PET?
Almost 50 million people worldwide are affected by Alzheimer’s disease (AD), the most common neurodegenerative disorder. Development of disease-modifying therapies would benefit from reliable, non-invasive positron emission tomography (PET) biomarkers for early diagnosis, monitoring of disease progr...
Gespeichert in:
| Veröffentlicht in: | Eur J Nucl Med Mol Imaging |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer Berlin Heidelberg
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6879437/ https://ncbi.nlm.nih.gov/pubmed/31342134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-019-04426-0 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|